Focused On LifeDeveloping novel therapies for serious diseases
Driven By ScienceRapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
Medivation is proud to be a 2014 Top WorkplaceLearn More
October 30, 2014 Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy Learn More